Neuren Pharmaceuticals LimitedASX: NEU

Neuren H1 2026 Financial Results Webinar on 26 August 2026

· Issued by Neuren Pharmaceuticals Limited via ASX

Filed with ASX · · 2 pages · English

Summary by 6ix AI

The webinar is scheduled for a specific date and time, and participants can register online. Neuren is focused on developing therapies for serious neurological disorders with limited treatment options. The announcement includes details about Neuren's drug candidates and ongoing clinical trials.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

1 of 2 Neuren (NEU) – ASX Announcement 21 August 2026 Neuren H1 2026 Financial Results Webinar on 26 August 2026 H1 2026 Financial Results Webinar | Wednesday, 26 August 2026 at 11.00 AM AEST You are invited to register using this link: ...

Neuren Pharmaceuticals Limited on 6ix

Earlier from Neuren Pharmaceuticals

Later from Neuren Pharmaceuticals

All Neuren Pharmaceuticals news releases